ADIL
Vanguard Group’s Adial Pharmaceuticals ADIL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.97K | Hold |
13,159
| – | – | ﹤0.01% | 4267 |
|
2025
Q1 | $8.34K | Buy |
+13,159
| New | +$8.34K | ﹤0.01% | 4260 |
|
2023
Q3 | – | Sell |
-203,358
| Closed | -$42.3K | – | 4539 |
|
2023
Q2 | $42.3K | Hold |
203,358
| – | – | ﹤0.01% | 4475 |
|
2023
Q1 | $71.2K | Sell |
203,358
-275,517
| -58% | -$96.4K | ﹤0.01% | 4433 |
|
2022
Q4 | $103K | Sell |
478,875
-137,980
| -22% | -$29.7K | ﹤0.01% | 4388 |
|
2022
Q3 | $216K | Buy |
616,855
+26,003
| +4% | +$9.11K | ﹤0.01% | 4404 |
|
2022
Q2 | $792K | Hold |
590,852
| – | – | ﹤0.01% | 4158 |
|
2022
Q1 | $1.19M | Hold |
590,852
| – | – | ﹤0.01% | 4156 |
|
2021
Q4 | $1.6M | Sell |
590,852
-3,591
| -0.6% | -$9.69K | ﹤0.01% | 4123 |
|
2021
Q3 | $2.55M | Buy |
594,443
+9,408
| +2% | +$40.4K | ﹤0.01% | 3986 |
|
2021
Q2 | $1.49M | Buy |
585,035
+370,238
| +172% | +$944K | ﹤0.01% | 4050 |
|
2021
Q1 | $520K | Buy |
214,797
+18,000
| +9% | +$43.6K | ﹤0.01% | 4129 |
|
2020
Q4 | $335K | Hold |
196,797
| – | – | ﹤0.01% | 4024 |
|
2020
Q3 | $439K | Sell |
196,797
-86,112
| -30% | -$192K | ﹤0.01% | 3836 |
|
2020
Q2 | $393K | Hold |
282,909
| – | – | ﹤0.01% | 3820 |
|
2020
Q1 | $368K | Hold |
282,909
| – | – | ﹤0.01% | 3734 |
|
2019
Q4 | $682K | Hold |
282,909
| – | – | ﹤0.01% | 3730 |
|
2019
Q3 | $424K | Sell |
282,909
-10,999
| -4% | -$16.5K | ﹤0.01% | 3848 |
|
2019
Q2 | $494K | Sell |
293,908
-9,800
| -3% | -$16.5K | ﹤0.01% | 3829 |
|
2019
Q1 | $1.04M | Buy |
303,708
+264,726
| +679% | +$908K | ﹤0.01% | 3620 |
|
2018
Q4 | $200K | Buy |
+38,982
| New | +$200K | ﹤0.01% | 3904 |
|